Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

What's Going On With Incyte Stock Monday? - Incyte (NASDAQ:INCY)

Summary by Benzinga
Early ASH 2025 data shows Incyte's INCA033989 delivers spleen, anemia and symptom improvements in mutCALR myelofibrosis.

2 Articles

BenzingaBenzinga
Center

What's Going On With Incyte Stock Monday? - Incyte (NASDAQ:INCY)

Early ASH 2025 data shows Incyte's INCA033989 delivers spleen, anemia and symptom improvements in mutCALR myelofibrosis.

·New York, United States
Read Full Article
The Business TimesThe Business Times

Incyte Corporation (INCY) Discusses mutCALR Data and Therapeutic Advances in Myeloproliferative Neoplasms at ASH Transcript

Conference Call Participants Claire HarrisonJohn MascarenhasBethan PsailaBrian Abrahams – RBC Capital Markets, Research DivisionErik Lavington – Mizuho Securities USA LLC, Research DivisionMichael Schmidt – Guggenheim Securities, LLC, Research DivisionSrikripa Devarakonda – Truist Securities, Inc., Research DivisionTazeen Ahmad – BofA Securities, Research DivisionGavin Clark-Gartner – Evercore ISI Institutional Equities, Research DivisionMarc Fr…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Business Times broke the news in on Sunday, December 7, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Royal Bank of Canada icon

Royal Bank of Canada

Orlando icon

Orlando

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal